SEC Form 4 · accession 0001209191-16-092204
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Stack
Officer — CEO and Chairman · Director
Period of report
Jan 15, 2016
Accepted (ET)
Jan 19, 2016 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 15, 2016 | M | 15,000 | $1.61 | A | 15,285 | D | |
| Common StockF3 | Jan 15, 2016 | S | 1,000 | $62.55 | D | 14,285 | D | |
| Common StockF4 | Jan 15, 2016 | S | 9,608 | $63.69 | D | 4,677 | D | |
| Common StockF5 | Jan 15, 2016 | S | 4,392 | $64.46 | D | 285 | D | |
| Common StockF6 | holding | — | — | — | 18,596 | I | By Stack Schroon Mohawk FLP | |
| Common StockF7 | holding | — | — | — | 1,208 | I | By LCK Investment LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F8 | $1.61 | Jan 15, 2016 | M | 15,000 | D | — | Sep 2, 2020 | Common Stock | 15,000 | 70,695 | D |
Explanation of responses
- F1The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2Includes 109 shares of common stock acquired under the issuer's employee stock purchase plan in December 2015.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.04 to $62.88, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3, 4 and 5.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.17 to $64.15, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.17 to $65.06, inclusive.
- F6Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
- F7Mr. Stack and his wife are the owners of LCK Investment LLC.
- F8The option vested as to 50% of the option shares on February 2, 2011, 19,377 option shares vested on February 3, 2011, and the remaining option shares vested in successive equal monthly installments for the subsequent 19 months.